Abstract:
When a pharmaceutical company raises a precise problem with a Market Research Institute, the resulting study and the conclusions are given to the client in the form of an exact answer to his questions . The statistical data used is "organised", in terms of the problem. We can say that the problem has been well identified and that, consequently, the data of the study has been organised to solve the problem. But if it is a question of collective surveys which provide solutions to many problems we find two difficulties: - the first one is to identify the problems; for which the collective survey must create information. - the second one, consequent upon the first, is to organise the results of the collective study so that they can be used in an easy way. DOREMA tried to get this work done and published a small booklet on this subject. We had two intentions by doing this: - to simplify the training of new market research executives in the pharmaceutical industry - to guide our own conception in regard to the presentation of our studies .
Research Papers
Which way should we go?
Catalogue: Seminar 1971: Practice And Problems In International Pharmaceutical Marketing Research
Author: A. I. Jowett
 
May 3, 1971
Research Papers
The German health care system
Catalogue: EphMRA/ESOMAR Conference 1994: Meeting The Pressures By Intelligent Resourcing
Author: Dieter Korczak
Company: GP Forschungsgruppe
June 1, 1994
Research Papers
Changes in patient behavior in seeking medical help
Catalogue: Global Healthcare 2006
Author: Hongfei Zhang
 
February 6, 2006
